Image used for representational purposes only. (File photo | ANI)
India

Centre proposes strict rules for storage and distribution of drugs

The proposal aims to ensure that the quality, safety, efficacy and integrity of pharmaceutical products are maintained throughout the distribution chain, from the manufacturer or importer to the point of supply to the patient.

Kavita Bajeli-Datt

NEW DELHI: The Union Health Ministry has proposed the incorporation of Good Storage and Distribution Practices (GSDP) guidelines for pharmaceutical products into the Drugs Rules, 1945.

The proposal aims to ensure that the quality, safety, efficacy and integrity of pharmaceutical products are maintained throughout the distribution chain, from the manufacturer or importer to the point of supply to the patient.

The proposed framework builds upon the GSDP guidance developed by the Central Drugs Standard Control Organisation (CDSCO).

The guidelines seek to ensure the quality and identity of pharmaceutical products at every stage of the distribution process, including procurement, purchasing, storage, distribution, transportation, documentation and record-keeping.

Maintaining appropriate storage and distribution conditions is essential to preserving the quality and integrity of pharmaceutical products beyond the manufacturing stage.

The proposed GSDP framework seeks to address potential risks associated with their handling and movement across the supply chain, including deterioration, contamination, mix-ups, falsification, diversion and unauthorised distribution.

The incorporation of GSDP requirements into the Drugs Rules, 1945, is expected to strengthen the regulatory framework governing pharmaceutical distribution and support effective regulatory oversight, inspection and enforcement by the Central and State drug-control authorities.

“It will also promote robust documentation, record-keeping and traceability, while enhancing accountability among manufacturers, importers, wholesalers, distributors, stockists and other entities involved in the distribution process,” officials said.

The proposed guidelines will further strengthen assurance that pharmaceutical products remain within specified quality and environmental conditions during storage and transportation, thereby reducing the risk of deterioration, contamination, mix-ups, falsification, diversion and unauthorised distribution.

This will support the availability of pharmaceutical products of assured quality to patients and healthcare providers, they added.

“The proposed amendment represents an important step towards strengthening India's pharmaceutical quality-management system and ensuring that the quality established at the manufacturing stage is maintained throughout the supply chain until the product reaches the patient,” officials said.

The ministry has invited comments from stakeholders and members of the public on the draft regulation.

‘Nuclear war cannot be won, must never be fought’: Trump, Putin and Xi adopt peace declaration after historic talks

Cyclone Akvan to cross AP-Odisha coast near Gopalpur by Friday noon, wind speeds up to 110 kmph

Rahul Gandhi says India has become ‘side player’ in global affairs as Pakistan negotiates US-Iran peace

The controversy surrounding Arunachal’s Siang Dam

Centre eases PUC renewal norms for newer BS-VI vehicles, tightens checks for older ones